GRC-15300

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameGRC-15300
Drug Alias NameGRC-17173GRC-15300SAR-292833
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 3 channel antagonists
TargetsTransient receptor potential cation channel subfamily V member 3
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesUkraine +[7] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A